Population health management programs are paying off, according to a survey of healthcare managers. More than half of respondents expect to recoup investments into these programs within 3 to 4 years, KPMG LLP found.
Population health management programs are paying off, according to a survey of healthcare managers. More than half of respondents expect to recoup investments into these programs within 3 to 4 years, KPMG LLP found.
Respondents are using population health management programs as a way to reduce avoidable medical costs and variability in care, according to West Johnson, a KPMG advisory partner who heads provider transformation.
“Preventive care is given a big priority in these programs, since they deliver improvements in efficient and effective care with a high degree of patient engagement,” Mr Johnson said in a statement.
More than a third (36%) of respondents say preventive care is the biggest clinical benefit of population health management programs, followed by developing evidence-based clinical protocols to improve the efficiency of care (23%) and managing chronic diseases (21%).
Only 14% of respondents said they do not see recouping the cost of the programs, but 20% expects the investment to pay off in 1 to 2 years, 36% expects 3 or 4 years, and 29% estimates 5 or more years.
Costs are the biggest challenge when implementing a population management program, according to 42% of respondents. However, a quarter also said getting staff and physicians comfortable with the approach, which requires greater collaboration and integration among providers and patients, is the second biggest challenge, followed by interoperability (19%) and coming to terms with new payer relationships (14%).
“Healthcare providers are facing a seismic shift in the coming years, largely because government and commercial payers will increasingly decline to pay for avoidable hospital visits,” Joe Kuehn, a KPMG partner with the healthcare advisory practice, said. “Providers and other participants in the care delivery system need the real time data and analytic tools to not only manage and improve the quality of care provided, but also the ability to measure costs to operate efficiently.”
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen